The marine sponge Verongia aerophoba (syn. Aplysina aerophoba) accumul
ates isofistularin-3 and aerophobin-2 as major brominated isoxazoline
alkaloids. Following disrupture of the compartmentation (e.g. by wound
ing) both isofistularin-3 and aerophobin-2 are enzymatically converted
into aeroplysinin-1 which in turn gives rise to a dienone. Aeroplysin
in-1 and dienone were shown to exhibit pronounced biological activitie
s in various bioassays with marine organisms (bacteria, algae and moll
uscs) whereas their biogenetic precursors isofistularin-3 and aerophob
in-2 were either inactive or exhibited only marginal activity. In the
agar plate diffusion assay, aeroplysinin-1 and dienone were antibiotic
ally active against eight different Gram-positive or Gram-negative mar
ine bacteria including Alteromonas, Moraxella and Vibrio spp. Towards
the marine Photobacterium phosphoreum the EC(50)s Of aeroplysinin-1 an
d dienone were 3.45 and 1.37 mu M, respectively. Both compounds inhibi
ted also the growth of the marine microalgae Coscinodiscus wailesii an
d Prorocentrum minimum. Towards the former, the EC(50)s of aeroplysini
n-1 and dienone were 5.6 and 27.9 mu M, respectively. In addition to t
heir growth inhibitory activity, aeroplysinin-1 and dienone were algic
idal as evident by their damaging effects on the algal cellular membra
nes. The polyphagous marine gastropod Littorina littorea was repelled
when exposed to either aeroplysinin-1 or dienone that were added to se
awater. The EC(50) of the most active compound aeroplysinin-1 was obse
rved at 0.1 mM. It is suggested that the enzymatically catalysed conve
rsion of brominated metabolites in V. aerophoba represents a wound-ind
uced defense mechanism hitherto unreported from the marine environment
.